Clinical trial
FinnTrunk, EVLA and Optimal Timing of Sclerotherapy
NCT04774939 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FinnTrunk, EVLA and Optimal Timing of Sclerotherapy
- Lead sponsor
- Turku University Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 15, 2021
- Completion date
- March 15, 2030
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
venous reflux